Eur Rev Med Pharmacol Sci 2020; 24 (22): 11716-11718
DOI: 10.26355/eurrev_202011_23818

Indwelling pleural catheters for malignancy related pleural effusions

A. Aujayeb, K. Jackson

Respiratory and Acute Medicine Consultant, Northumbria HealthCare NHS Foundation Trust, Care of Tracy Groom, Cramlington, Northumberland, NE23 6NZ, UK. avinash.aujayeb@nhct.nhs.uk


OBJECTIVE: Malignant Pleural Effusion (MPE) carries significant morbidity and mortality. Indwelling pleural catheters (IPCs) are established in the management pathway. Large case reviews add to the evidence base regarding safety and efficacy.

PATIENTS AND METHODS: 168 patients had an IPC inserted between January 2012 and December 2018 in a large pleural centre. Data on outcomes and complications were obtained from the patients’ notes, laboratory and radiographic findings. A descriptive statistical methodology was applied.

RESULTS: 168 IPCs were inserted in a predominantly male population. The overall complication rate is 13%. The incidence of any individual complication such as infection, metastatic seeding, drain displacement, and loculations are all less than previously described.

CONCLUSIONS: This case review adds to the large body of evidence that IPCs are safe and have minimal complications. Specific factors enabling this are the use of pre-operative antibiotics, the use of theatre space, and the experience of the pleural interventional physicians.

Free PDF Download

To cite this article

A. Aujayeb, K. Jackson
Indwelling pleural catheters for malignancy related pleural effusions

Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 22
Pages: 11716-11718
DOI: 10.26355/eurrev_202011_23818